● Successfully obtained in the EU CE access certification
● Enter the whitelist for Chinese export qualifications
The reagent is used for the clinical in vitro qualitative detection of new coronavirus (2019-nCoV) antibodies in human serum, plasma or whole blood.
Advantage:
- Flexible samples: fingertip whole blood (no need for centrifugation), serum, plasma
- Quick screening: results can be interpreted in 15 minutes
- Differentiating types: combined detection and distinguishing IgM/IgG antibodies
- Manual interpretation: no equipment is needed, easy for general medical institutions to carry out a wide range
Specification
Sample type: serum, plasma, whole blood,fingertip blood
Report time: 15min
Storage : 4-30℃, sealed and kept away from light and dry
Validity period :18 months
Product specifications: 50 tests/box
It is only used as a supplementary test indicator for suspected cases with a negative nucleic acid test of the new coronavirus or used in conjunction with nucleic acid testing in the diagnosis of suspected cases.
It cannot be used as a basis for the diagnosis and exclusion of pneumonia caused by new coronavirus infection, and is not suitable for screening of the general population. Only for medical institutions.